Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 14;17(6):1030.
doi: 10.3390/nu17061030.

A Narrative Review on Higenamine: Pharmacological Properties and Clinical Applications

Affiliations
Review

A Narrative Review on Higenamine: Pharmacological Properties and Clinical Applications

Hanghao Shi et al. Nutrients. .

Abstract

Background: Higenamine, a bioactive alkaloid derived from plants such as Aconitum and Annona squamosa, has been traditionally used in Chinese medicine for treating heart diseases like bradycardia, arrhythmia, and heart failure. It exhibits multiple pharmacological effects, including anti-oxidative stress, improved cellular energy metabolism, anti-apoptosis, and enhanced erectile dysfunction.

Aim and methods: To investigate the reasons for these functions of higenamine and its application in the clinic, the literature of the database was searched and read in this study.

Results: As a non-selective β-agonist, higenamine activates both β1- and β2-adrenergic receptors, leading to cardiovascular benefits such as increased heart rate and myocardial contractility, as well as bronchodilation. It has also been studied for its potential in weight loss, anti-inflammatory properties, and antioxidant properties, with applications in treating asthma, cardiovascular diseases, and ischemia-reperfusion injuries. However, its clinical use is limited by the need for further research on its long-term safety, pharmacokinetics, and interactions with other drugs. Despite its promising therapeutic potential, higenamine's inclusion in the World Anti-Doping Agency's banned list highlights concerns over its stimulant effects and safety in athletic contexts.

Conclusions: Future studies should focus on optimizing its clinical applications while ensuring safety and efficacy. In terms of clinical applications, future research will also be able to explore more possibilities to use higenamine more in the treatment of diseases.

Keywords: PI3K/Akt signaling pathway; anti-doping; anti-inflammatory; antioxidant; cardiovascular protection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The chemical structure of higenamine.
Figure 2
Figure 2
The chemical structure of catecholamine, epinephrine, norepinephrine, and dopamine.
Figure 3
Figure 3
The signal pathway influenced by higenamine. (Red arrows: Standing for pathway of NF-kB influencing IL-1β, resulting inflammatory; Blue arrows: Standing for pathway of PI3K/Akt effecting IL-1β, leading to cell apoptosis. Higenamine can inhibit these two pathways).

References

    1. Wen J., Li M., Zhang W., Wang H., Bai Y., Hao J., Liu C., Deng K., Zhao Y. Role of Higenamine in Heart Diseases: A Mini-Review. Front. Pharmacol. 2021;12:798495. doi: 10.3389/fphar.2021.798495. - DOI - PMC - PubMed
    1. Zhao X., Yuan Y., Wei H., Fei Q., Luan Z., Wang X., Xu Y., Lu J. Identification and characterization of higenamine metabolites in human urine by quadrupole-orbitrap LC-MS/MS for doping control. J. Pharm. Biomed. Anal. 2022;214:114732. doi: 10.1016/j.jpba.2022.114732. - DOI - PubMed
    1. Kam S.C., Do J.M., Choi J.H., Jeon B.T., Roh G.S., Chang K.C., Hyun J.S. The relaxation effect and mechanism of action of higenamine in the rat corpus cavernosum. Int. J. Impot. Res. 2012;24:77–83. doi: 10.1038/ijir.2011.48. - DOI - PubMed
    1. Muniz-Santos R., Avezum J., Abidão-Neto B., Cameron L.C. Dietary higenamine from Annonaceae family fruits as a possible source of unintentional doping. Forensic Sci. Int. 2023;342:111539. doi: 10.1016/j.forsciint.2022.111539. - DOI - PubMed
    1. Wellstein A., Belz G.G., Palm D. Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots. J. Pharmacol. Exp. Ther. 1988;246:328–337. doi: 10.1016/S0022-3565(25)21024-2. - DOI - PubMed

LinkOut - more resources